senate Bill S4640

2021-2022 Legislative Session

Relates to consideration and prescription of non-opioid treatment alternatives for treatment of neuromusculoskeletal conditions

download bill text pdf

Sponsored By

Current Bill Status Via A273 - Passed Senate & Assembly


  • Introduced
  • In Committee
  • On Floor Calendar
    • Passed Senate
    • Passed Assembly
  • Delivered to Governor
  • Signed/Vetoed by Governor

Your Voice

do you support this bill?

Please enter your contact information

Home address is used to determine the senate district in which you reside. Your support or opposition to this bill is then shared immediately with the senator who represents you.

Optional services from the NY State Senate:

Create an account. An account allows you to officially support or oppose key legislation, sign petitions with a single click, and follow issues, committees, and bills that matter to you. When you create an account, you agree to this platform's terms of participation.

Include a custom message for your Senator? (Optional)

Enter a message to your senator. Many New Yorkers use this to share the reasoning behind their support or opposition to the bill. Others might share a personal anecdote about how the bill would affect them or people they care about.

Actions

view actions (18)
Assembly Actions - Lowercase
Senate Actions - UPPERCASE
May 25, 2022 returned to assembly
passed senate
3rd reading cal.1332
substituted for s4640
May 25, 2022 substituted by a273
May 17, 2022 advanced to third reading
May 16, 2022 2nd report cal.
May 11, 2022 1st report cal.1332
Jan 05, 2022 referred to health
returned to senate
died in assembly
Jun 03, 2021 referred to health
delivered to assembly
passed senate
Apr 28, 2021 advanced to third reading
Apr 27, 2021 2nd report cal.
Apr 26, 2021 1st report cal.731
Feb 08, 2021 referred to health

Votes

view votes

May 9, 2022 - Health committee Vote

S4640
13
0
committee
13
Aye
0
Nay
1
Aye with Reservations
0
Absent
1
Excused
0
Abstained
show Health committee vote details

Health Committee Vote: May 9, 2022

aye wr (1)
excused (1)

Apr 26, 2021 - Health committee Vote

S4640
14
0
committee
14
Aye
0
Nay
1
Aye with Reservations
0
Absent
0
Excused
0
Abstained
show Health committee vote details

Health Committee Vote: Apr 26, 2021

aye wr (1)

Co-Sponsors

S4640 (ACTIVE) - Details

See Assembly Version of this Bill:
A273
Law Section:
Public Health Law
Laws Affected:
Amd §3331, Pub Health L
Versions Introduced in 2019-2020 Legislative Session:
S5867, A8256

S4640 (ACTIVE) - Summary

Requires a practitioner to consider and prescribe non-opioid treatment alternatives for treatment of neuromusculoskeletal conditions.

S4640 (ACTIVE) - Sponsor Memo

S4640 (ACTIVE) - Bill Text download pdf

 
                     S T A T E   O F   N E W   Y O R K
 ________________________________________________________________________
 
                                   4640
 
                        2021-2022 Regular Sessions
 
                             I N  S E N A T E
 
                             February 8, 2021
                                ___________
 
 Introduced  by Sens. RIVERA, HARCKHAM -- read twice and ordered printed,
   and when printed to be committed to the Committee on Health
 
 AN ACT to amend the public health law, in relation to consideration  and
   prescription  of  non-opioid  treatment  alternatives for treatment of
   neuromusculoskeletal conditions

   THE PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND  ASSEM-
 BLY, DO ENACT AS FOLLOWS:
 
   Section  1. Section 3331 of the public health law is amended by adding
 a new subdivision 9 to read as follows:
   9. (A) WHEN A PATIENT SEEKS  TREATMENT  FOR  ANY  NEUROMUSCULOSKELETAL
 CONDITION  THAT  CAUSES  PAIN,  WHERE A PRACTITIONER CONSIDERS AN OPIOID
 TREATMENT, THE PRACTITIONER SHALL CONSIDER, DISCUSS  WITH  THE  PATIENT,
 AND,  AS  APPROPRIATE,  REFER OR PRESCRIBE NON-OPIOID TREATMENT ALTERNA-
 TIVES, BASED ON  THE  PRACTITIONER'S  CLINICAL  JUDGMENT  AND  FOLLOWING
 GENERALLY  ACCEPTED  NATIONAL  PROFESSIONAL OR TREATMENT GUIDELINES, AND
 CONSISTENT WITH  PATIENT  PREFERENCE  AND  CONSENT,  BEFORE  STARTING  A
 PATIENT  ON OPIOID TREATMENT. FOR THE PURPOSES OF THIS SUBDIVISION, NON-
 OPIOID TREATMENT ALTERNATIVES INCLUDE, BUT ARE NOT LIMITED TO:  ACUPUNC-
 TURE, CHIROPRACTIC,  MASSAGE  THERAPY,  PHYSICAL  THERAPY,  OCCUPATIONAL
 THERAPY, COGNITIVE BEHAVIORAL THERAPY, NON-OPIOID MEDICATIONS, INTERVEN-
 TIONAL  TREATMENTS  AND  NON-CLINICAL  ACTIVITIES  SUCH AS EXERCISE. THE
 PRACTITIONER SHALL INFORM THE PATIENT THAT SOME TREATMENTS  MAY  NOT  BE
 COVERED BY THE PATIENT'S HEALTH COVERAGE.
   (B)  THE REQUIREMENTS OF THIS SUBDIVISION SHALL NOT APPLY FOR PATIENTS
 BEING TREATED UNDER ANY OF THE  FOLLOWING  CIRCUMSTANCES:  TREATMENT  OF
 CANCER;  HOSPICE OR OTHER END-OF-LIFE CARE; POST-SURGERY TREATMENT IMME-
 DIATELY FOLLOWING A SURGICAL PROCEDURE; OR IN A MEDICAL EMERGENCY.   FOR
 PURPOSES  OF THIS SUBDIVISION, "MEDICAL EMERGENCY" MEANS AN ACUTE INJURY
 OR ILLNESS THAT POSES AN IMMEDIATE RISK TO A PERSON'S LIFE OR HEALTH.
   § 2. This act shall take effect immediately.
 
  EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets
                       [ ] is old law to be omitted.
                                                            LBD00473-01-1

Comments

Open Legislation is a forum for New York State legislation. All comments are subject to review and community moderation is encouraged.

Comments deemed off-topic, commercial, campaign-related, self-promotional; or that contain profanity, hate or toxic speech; or that link to sites outside of the nysenate.gov domain are not permitted, and will not be published. Attempts to intimidate and silence contributors or deliberately deceive the public, including excessive or extraneous posting/posts, or coordinated activity, are prohibited and may result in the temporary or permanent banning of the user. Comment moderation is generally performed Monday through Friday. By contributing or voting you agree to the Terms of Participation and verify you are over 13.